阅读说明：本技术 一种碳水溶酶组合物及其制备方法和应用 (Carbohydrate-lysozyme composition and preparation method and application thereof ) 是由 罗赛南 于 2021-10-13 设计创作，主要内容包括：本发明提出了一种碳水溶酶组合物及其制备方法和应用,涉及注射药物技术领域。一种碳水溶酶组合物,其包括以下体积份的原料：利多卡因注射液4-7份、碳酸氢钠注射液8-12份、地塞米松注射液1-3份和生理盐水40-60份。本发明药物组合物通过局部注射,发挥了原料间的协同增效作用,能够有效刺激局部脂肪细胞内的脂肪酶数目增加,继而刺激蛋白质的活化,使细胞内的脱氧核甘三磷酸转化成脱氧核甘酸,促使脂肪的活化而增加切断脂肪酸,使其分解成细小状态,随着身体的新陈代谢由淋巴系统排出体外,并可锁住皮肤细胞水分,供给皮下细胞营养成份,促进皮下细胞活性,从而起到缓解脂肪堆积、褶皱和不平整的状态。(The invention provides a carbohydrate-lysozyme composition and a preparation method and application thereof, relating to the technical field of injection medicines. A carbohydrate-lysozyme composition comprises the following raw materials in parts by volume: 4-7 parts of lidocaine injection, 8-12 parts of sodium bicarbonate injection, 1-3 parts of dexamethasone injection and 40-60 parts of physiological saline. The pharmaceutical composition provided by the invention can effectively stimulate the increase of the number of lipases in local fat cells and further stimulate the activation of protein, so that intracellular deoxyribo-triphosphate is converted into deoxyribo-glycine, the activation of fat is promoted to increase and cut off fatty acid, the fatty acid is decomposed into a fine state, the fatty acid is discharged from the body by a lymphatic system along with the metabolism of the body, and the moisture of skin cells can be locked, so that the nutritional ingredients of subcutaneous cells are supplied, and the activity of the subcutaneous cells is promoted, thereby relieving the states of fat accumulation, wrinkles and unevenness.)

1. A carbohydrate-lysozyme composition is characterized by comprising the following raw materials in parts by volume: 4-7 parts of lidocaine injection, 8-12 parts of sodium bicarbonate injection, 1-3 parts of dexamethasone injection and 40-60 parts of physiological saline.

2. The carbohydrate lysozyme composition of claim 1, further comprising the following raw materials in parts by volume: 5-10 parts of compound gastrodine injection and 3-8 parts of levocarnitine injection.

3. The carbohydrate lysozyme composition of claim 2, wherein the carbohydrate lysozyme composition comprises the following raw materials in parts by volume: 5 parts of lidocaine injection, 10 parts of sodium bicarbonate injection, 2 parts of dexamethasone injection, 8 parts of compound gastrodin injection, 5 parts of levocarnitine injection and 50 parts of normal saline.

4. The carbohydrate lysozyme composition of claim 1, further comprising the following raw materials in parts by volume: 15-25 parts of compound calcium carbonate injection, 0.8-1.2 parts of vitamin B1 injection, 0.8-1.4 parts of vitamin B6 injection and 0.6-1.5 parts of vitamin B12 injection.

5. The carbohydrate lysozyme composition of claim 4, wherein the carbohydrate lysozyme composition comprises the following raw materials in parts by volume: 5 parts of lidocaine injection, 10 parts of sodium bicarbonate injection, 2 parts of dexamethasone injection, 20 parts of compound calcium carbonate injection, 1 part of vitamin B1 injection, 1 part of vitamin B6 injection, 1 part of vitamin B12 injection and 50 parts of normal saline.

6. A process according to any one of claims 1 to 5, comprising the steps of:

weighing the raw materials according to the volume, mixing the raw materials except the normal saline, adding the normal saline while stirring, continuously stirring uniformly, subpackaging, sealing by melting and sterilizing to obtain the carbohydrate-lysozyme composition.

7. The method of claim 6, wherein the time for stirring the physiological saline solution is 10-30 min.

8. The method for preparing a carbohydrate-containing lysozyme composition according to claim 6, wherein the dispensing comprises the following steps: the well mixed liquid is dispensed into 1-2mL ampoules.

9. A carbohydrate lysozyme injection prepared using a carbohydrate lysozyme composition according to any one of claims 1 to 5.

10. Use of the carbolysin injection according to claim 9 in the field of facial cosmetics.

Technical Field

The invention relates to the technical field of injection medicines, and particularly relates to a carbohydrate-lysozyme composition and a preparation method and application thereof.

Background

With the development of economic society, the pace of life is also increasing, and various stresses to which people are subjected are also steadily increasing, so that the balance of human metabolism may be disrupted, the supply of nutrients required by the skin tends to be slow, and the pigment blasts become active. In addition to the influence of external factors (such as strong ultraviolet irradiation or wrong use of cosmetics, etc.), the skin is easily roughened, dull, and even spotty. In addition, the human face has the following problems: developed masseter, rough facial lines, water retention, facial edema, fat accumulation, obvious cheek flesh sensation, loose skin, drooping cheek contours and the like.

The problem of edema, obesity or fat on the face causes serious troubles to the life of modern women. The problem of the female is solved by surgical fat suction, injection of a face thinning needle and the like, but the mode has extremely high risk and even endangers life; women also exercise facial muscles to achieve the purpose of face slimming, but the method is hard to maintain, and improper operation possibly causes excessive exercise of the facial muscles, so that another form of facial obesity is caused, and the operation is more difficult; the traditional Chinese medicine is taken orally to lose weight, but the traditional Chinese medicine generally acts on the whole body, and almost cannot be used for local face thinning, so that the effect is very little.

For loose wrinkles on the face, the theory is described as the reduction of collagen secretion and the natural aging relaxation, and for the condition of over-age and particularly severe skin relaxation, the condition can be relatively improved, but the ideal effect can not be completely achieved. In the prior art, facial skin is usually improved in a short time after the facial mask is applied to the face by adopting modes of applying the facial mask and the like aiming at facial skin relaxation and aging. For a mask product, the using effect mainly depends on the absorption efficiency of skin on nutrient components in the mask, and the existing mask has the defect that the absorption efficiency is not high after application, so that the nutrient components are lost.

Therefore, the research of researchers in this field is directed to develop a cosmetic drug with better efficacy against the problems of edema and heaviness of the middle face and loose wrinkles of the face, and a safe method of using the same.

Disclosure of Invention

The invention aims to provide a carbohydrate lysozyme composition which can effectively improve the conditions of facial fat overfilling and skin laxity.

It is another object of the present invention to provide a method for preparing a carbohydrate-lyase composition, which is simple in preparation scheme.

Another object of the present invention is to provide a use of a carbohydrate lysozyme composition in the field of facial cosmetics.

The technical problem to be solved by the invention is realized by adopting the following technical scheme.

In one aspect, the present application provides a carbohydrate-lysozyme composition, which includes the following raw materials in parts by volume: 4-7 parts of lidocaine injection, 8-12 parts of sodium bicarbonate injection, 1-3 parts of dexamethasone injection and 40-60 parts of physiological saline.

Furthermore, the raw materials also comprise 5-10 parts of compound gastrodine injection and 3-8 parts of levocarnitine injection.

Furthermore, the raw materials also comprise 15 to 25 parts of compound calcium carbonate injection, 0.8 to 1.2 parts of vitamin B1 injection, 0.8 to 1.4 parts of vitamin B6 injection and 0.6 to 1.5 parts of vitamin B12 injection.

In another aspect, the present embodiments provide a method for preparing a carbohydrate-lyase composition, which includes the following steps: weighing the raw materials according to the volume, mixing the raw materials except the normal saline, adding the normal saline while stirring, continuously stirring uniformly, subpackaging, sealing by melting and sterilizing to obtain the carbohydrate-lysozyme composition.

In another aspect, the present invention provides a carbohydrate lysozyme injection prepared from the above carbohydrate lysozyme composition, and an application of the carbohydrate lysozyme injection in the field of facial beauty treatment.

Compared with the prior art, the embodiment of the invention has at least the following advantages or beneficial effects:

aiming at the condition of excessive facial fat filling, the pharmaceutical composition is compounded by lidocaine, sodium bicarbonate, dexamethasone, compound gastrodine, levocarnitine and normal saline, and the synergistic effect is exerted through local injection; the lidocaine injection has good surface penetrating power and anesthetic effect, and improves the injection effect; the sodium bicarbonate injection and the levocarnitine injection are matched to effectively stimulate the increase of the number of lipase in local fat cells, further stimulate the activation of protein, convert the deoxyribonuclein triphosphate in the cells into deoxyribonuclein acid, promote the activation of fat, increase and cut off the fatty acid, decompose the fatty acid into a fine state, and are matched with the compound gastrodin injection to dredge channels and promote circulation, the fat is discharged out of a human body from a lymphatic system along with the metabolism of the human body, and finally the dexamethasone injection is matched to diminish inflammation, inhibit immunity, comprehensively play the roles of relieving fat accumulation and reducing facial fat.

Aiming at the condition of facial skin relaxation, the invention adopts lidocaine, sodium bicarbonate, dexamethasone, compound calcium carbonate, vitamin B1, vitamin B6 and vitamin B12 for compound collocation, wherein the lidocaine injection has good surface penetrating power and anesthetic effect, and improves the injection effect; the compound calcium carbonate, the vitamin B1, the vitamin B6 and the vitamin B12 are adopted to lock the moisture of skin cells, supply the nutrition components to subcutaneous cells, promote the activity of the subcutaneous cells, promote the growth of the cells and make the facial skin plump, thereby relieving the state of skin wrinkles and unevenness and providing a new drug combination selection for clinical treatment.

Detailed Description

In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.

It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present invention will be described in detail below with reference to specific examples.

A carbohydrate-lysozyme composition comprises the following raw materials in parts by volume: 4-7 parts of lidocaine injection, 8-12 parts of sodium bicarbonate injection, 1-3 parts of dexamethasone injection and 40-60 parts of physiological saline.

In some embodiments of the present invention, the above-mentioned carbohydrate-lyase composition further comprises the following raw materials in parts by volume: 5-10 parts of compound gastrodine injection and 3-8 parts of levocarnitine injection.

In some embodiments of the present invention, the above-mentioned carbohydrate-lyase composition comprises the following parts by volume of the raw materials: 5 parts of lidocaine injection, 10 parts of sodium bicarbonate injection, 2 parts of dexamethasone injection, 8 parts of compound gastrodin injection, 5 parts of levocarnitine injection and 50 parts of normal saline.

In some embodiments of the present invention, the above-mentioned carbohydrate-lyase composition further comprises the following raw materials in parts by volume: 15-25 parts of compound calcium carbonate injection, 0.8-1.2 parts of vitamin B1 injection, 0.8-1.4 parts of vitamin B6 injection and 0.6-1.5 parts of vitamin B12 injection. The vitamin B1 injection combines with pyrophosphoric acid into a coacetidase in vivo, participates in the oxidative decarboxylation reaction of pyruvic acid and a-ketoglutaric acid in sugar metabolism, and is necessary for sugar metabolism; the vitamin B6 injection is converted into pyridoxal phosphate in erythrocytes, and is used as a coenzyme to play a role in various metabolic functions of protein, carbohydrate and lipid and also participate in the conversion of tryptophan into nicotinic acid or 5-hydroxytryptamine; the vitamin B12 injection is involved in methyl conversion and folic acid metabolism in vivo, and promotes the conversion of 5-methyltetrahydrofolic acid into tetrahydrofolic acid.

In some embodiments of the present invention, the above-mentioned carbohydrate-lyase composition comprises the following parts by volume of the raw materials: 5 parts of lidocaine injection, 10 parts of sodium bicarbonate injection, 2 parts of dexamethasone injection, 20 parts of compound calcium carbonate injection, 1 part of vitamin B1 injection, 1 part of vitamin B6 injection, 1 part of vitamin B12 injection and 50 parts of normal saline.

A method of preparing a carbohydrate lysozyme composition comprising the steps of:

weighing the raw materials according to the volume, mixing the raw materials except the normal saline, adding the normal saline while stirring, continuously stirring uniformly, subpackaging, sealing by melting and sterilizing to obtain the carbohydrate-lysozyme composition.

In some embodiments of the present invention, the stirring time after the physiological saline is added is 10-30 min.

In some embodiments of the present invention, the subpackaging specifically comprises the following steps: the well mixed liquid is dispensed into 1-2mL ampoules. 1-2mL of injection is injected each time, which is more beneficial to the absorption of skin cells.

The carbolysin injection prepared from the carbolysin composition and the application thereof in the field of facial beautification.

The features and properties of the present invention are described in further detail below with reference to examples.

Example 1

A carbohydrate lysozyme composition comprising the following raw materials: 5mL of lidocaine injection, 10mL of sodium bicarbonate injection, 2mL of dexamethasone injection and 50mL of normal saline.

Sequentially adding the lidocaine injection, the sodium bicarbonate injection and the dexamethasone injection into a container for mixing, adding the physiological saline while stirring after uniformly mixing, stirring for 20min under a sterile environment, then subpackaging into 1mL ampoules, and carrying out sealing and sterilization to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Example 2

A carbohydrate lysozyme composition comprising the following raw materials: 4mL of lidocaine injection, 10mL of sodium bicarbonate injection, 2mL of dexamethasone injection and 60mL of normal saline.

Sequentially adding the lidocaine injection, the sodium bicarbonate injection and the dexamethasone injection into a container for mixing, adding the physiological saline while stirring after uniformly mixing, stirring for 15min under a sterile environment, then subpackaging into 2mL ampoules, and carrying out melt sealing and sterilization to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Example 3

A carbohydrate lysozyme composition comprising the following raw materials: 7mL of lidocaine injection, 8mL of sodium bicarbonate injection, 3mL of dexamethasone injection and 40mL of normal saline.

Sequentially adding the lidocaine injection, the sodium bicarbonate injection and the dexamethasone injection into a container for mixing, adding the physiological saline while stirring after uniformly mixing, stirring for 20min under a sterile environment, then subpackaging into 1mL ampoules, and carrying out sealing and sterilization to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Example 4

A carbohydrate lysozyme composition comprising the following raw materials: 6mL of lidocaine injection, 12mL of sodium bicarbonate injection, 1mL of dexamethasone injection and 55mL of normal saline.

Sequentially adding the lidocaine injection, the sodium bicarbonate injection and the dexamethasone injection into a container for mixing, adding the physiological saline while stirring after uniformly mixing, stirring for 30min under a sterile environment, then subpackaging into 1mL ampoules, and carrying out melt sealing and sterilization to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Example 5

A carbohydrate lysozyme composition comprising the following raw materials: 6mL of lidocaine injection, 12mL of sodium bicarbonate injection, 1mL of dexamethasone injection, 10mL of compound gastrodine injection, 3mL of levocarnitine injection and 55mL of normal saline.

Sequentially adding the lidocaine injection, the sodium bicarbonate injection, the dexamethasone injection, the compound gastrodine injection and the levocarnitine injection into a container for mixing, uniformly mixing, adding the physiological saline while stirring, stirring for 20min in an aseptic environment, subpackaging in a 1mL ampoule bottle, and carrying out sealing and sterilization to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Example 6

A carbohydrate lysozyme composition comprising the following raw materials: 5mL of lidocaine injection, 12mL of sodium bicarbonate injection, 1.5mL of dexamethasone injection, 5mL of compound gastrodin injection, 8mL of levocarnitine injection and 45mL of normal saline.

Sequentially adding the lidocaine injection, the sodium bicarbonate injection, the dexamethasone injection, the compound gastrodine injection and the levocarnitine injection into a container for mixing, uniformly mixing, adding the physiological saline while stirring, stirring for 25min in an aseptic environment, subpackaging in a 1mL ampoule bottle, and carrying out sealing and sterilization to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Example 7

A carbohydrate lysozyme composition comprising the following raw materials: 5mL of lidocaine injection, 10mL of sodium bicarbonate injection, 2mL of dexamethasone injection, 8mL of compound gastrodine injection, 5mL of levocarnitine injection and 50mL of normal saline.

Sequentially adding the lidocaine injection, the sodium bicarbonate injection, the dexamethasone injection, the compound gastrodine injection and the levocarnitine injection into a container for mixing, uniformly mixing, adding the physiological saline while stirring, stirring for 20min in an aseptic environment, subpackaging in 2mL ampoules, sealing by melting and sterilizing to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Example 8

A carbohydrate lysozyme composition comprising the following raw materials: 6mL of lidocaine injection, 11mL of sodium bicarbonate injection, 2mL of dexamethasone injection, 15mL of compound calcium carbonate injection, 1.2mL of vitamin B1 injection, 0.8mL of vitamin B6 injection, 1.5mL of vitamin B12 injection and 55mL of normal saline.

Sequentially adding lidocaine injection, sodium bicarbonate injection, dexamethasone injection, compound calcium carbonate injection, vitamin B1 injection, vitamin B6 injection and vitamin B12 injection into a container for mixing, stirring and adding normal saline at the same time after uniform mixing, stirring for 23min under a sterile environment, then subpackaging into a 1mL ampoule bottle, and carrying out melt sealing and sterilization to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Example 9

A carbohydrate lysozyme composition comprising the following raw materials: 4mL of lidocaine injection, 11mL of sodium bicarbonate injection, 1mL of dexamethasone injection, 25mL of compound calcium carbonate injection, 0.8mL of vitamin B1 injection, 1.4mL of vitamin B6 injection, 0.6mL of vitamin B12 injection and 52mL of normal saline.

Sequentially adding lidocaine injection, sodium bicarbonate injection, dexamethasone injection, compound calcium carbonate injection, vitamin B1 injection, vitamin B6 injection and vitamin B12 injection into a container for mixing, stirring and adding normal saline at the same time after uniform mixing, stirring for 20min under a sterile environment, then subpackaging into 1mL ampoules, and carrying out melt sealing and sterilization to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Example 10

A carbohydrate lysozyme composition comprising the following raw materials: 5mL of lidocaine injection, 10mL of sodium bicarbonate injection, 2mL of dexamethasone injection, 20mL of compound calcium carbonate injection, 1mL of vitamin B1 injection, 1mL of vitamin B6 injection, 1mL of vitamin B12 injection and 50mL of normal saline.

Sequentially adding lidocaine injection, sodium bicarbonate injection, dexamethasone injection, compound calcium carbonate injection, vitamin B1 injection, vitamin B6 injection and vitamin B12 injection into a container for mixing, stirring and adding normal saline at the same time after uniform mixing, stirring for 25min under a sterile environment, then subpackaging into 1mL ampoules, and carrying out melt sealing and sterilization to obtain the carbohydrate lysozyme injection.

And (3) extracting 1 ampoule of carbolysin injection as the acupoint injection, and selecting the part of the patient needing to be injected and filled for local injection.

Examples of the experiments

The effect of the carbolytic enzyme injection on facial fat accumulation is explored.

In this experimental example, 239 patients with facial fat accumulation symptoms were selected from the group consisting of people who were collected between 11 and 2020-12 months in 2015, and treated in 11 groups, wherein experimental groups 1 to 10 were injected with the carbohydrase injection prepared in examples 1 to 10, and experimental group 11 was a blank group and was injected with physiological saline. The experimental groups 1-11 were injected with 1mL each time, 1 injection each week for 4 consecutive weeks as one cycle, the next cycle started at a monthly interval after each cycle was completed, and the treatment time was 3 cycles. The treatment condition is counted after three cycles, wherein the facial fat accumulation symptom disappears to be healed, obvious improvement is changed into obvious effect, the effect improvement condition is general or no obvious improvement is changed into ineffective, the effective rate is counted, and the counting result is shown in table 1. Effective rate (number of healing people + number of effective people)/total number of people.

TABLE 1

As can be seen from Table 1, the carbohydrase injection solutions prepared in the experimental groups 1-10 of the present invention have a very good therapeutic effect on the symptoms of fat accumulation compared to the experimental group 11, especially the experimental groups 5-7 have the best effect in terms of both effective rate and cure rate, and the experimental groups 8-10 have decreased the effect by adding other raw materials on the basis of the raw materials of the experimental groups 1-4.

Secondly, the effect of the carbolysin injection on facial relaxation is explored.

In this experimental example, 294 patients with loose and wrinkled facial skin were selected from the group consisting of patients collected between 11 months and 2021 months and treated in 11 groups, wherein the experimental groups 1 to 10 were injected with the carbohydrase injection prepared in examples 1 to 10, and the experimental group 11 was a blank group and was injected with physiological saline. The experimental groups 1-11 were injected with 1mL each time, 1 injection each week for 4 consecutive weeks as one cycle, the next cycle started at a monthly interval after each cycle was completed, and the treatment time was 3 cycles. The treatment conditions are counted after three cycles, wherein the facial skin is loosened, wrinkles are obviously improved to be healed, better improvement is obvious, the effect improvement condition is general or no obvious improvement is ineffective, the effective rate is counted, and the statistical result is shown in table 2. Effective rate (number of healing people + number of effective people)/total number of people.

TABLE 2

Experimental group	Total number of people	The number of healed people	Number of effective people	Number of invalid persons	High efficiency
						1	27 persons	8 persons	16 persons	3 persons	88.89％
2	26 persons	10 persons	14 persons	2 persons	92.31％
						3	26 persons	8 persons	16 persons	2 persons	92.31％
4	26 persons	9 persons	16 persons	1 person	96.15％
						5	26 persons	8 persons	14 persons	4 persons	84.62％
6	27 persons	11 persons	13 persons	3 persons	88.89％
						7	27 persons	9 persons	15 persons	3 persons	88.89％
8	27 persons	18 persons	8 persons	1 person	96.30％
						9	27 persons	15 persons	11 persons	1 person	96.30％
10	28 persons	19 persons	9 persons	0 person	100％
						11	27 persons	2 persons	6 persons	19 persons	29.63％

As can be seen from Table 2, the carbolysin injections prepared in test groups 1-10 of the present invention showed very good therapeutic effects on the symptoms of facial skin laxity, especially the results of test groups 8-10 were the best in terms of both effective rate and cure rate, indicating that the lysin injections prepared in examples 8-10 are more suitable for patients with facial skin laxity.

In a typical proportion, Dingzhi, age 55, facial laxity and strong lines affect the overall facial beauty, and after two weeks of treatment by using the medicine prepared in the embodiment 7 of the invention, the patient has improved remarkably and the wrinkle symptoms basically disappear by facial diagnosis.

In summary, the present invention provides a carbohydrate-lysozyme composition, and a preparation method and applications thereof. Aiming at the condition of excessive facial fat filling, the pharmaceutical composition is compounded by lidocaine, sodium bicarbonate, dexamethasone, compound gastrodine, levocarnitine and normal saline, and the synergistic effect is exerted through local injection; the lidocaine injection has good surface penetrating power and anesthetic effect, and improves the injection effect; the sodium bicarbonate injection and the levocarnitine injection are matched to effectively stimulate the increase of the number of lipase in local fat cells, further stimulate the activation of protein, convert the deoxyribonuclein triphosphate in the cells into deoxyribonuclein acid, promote the activation of fat, increase and cut off the fatty acid, decompose the fatty acid into a fine state, and are matched with the compound gastrodin injection to dredge channels and promote circulation, the fat is discharged out of a human body from a lymphatic system along with the metabolism of the human body, and finally the dexamethasone injection is matched to diminish inflammation, inhibit immunity, comprehensively play the roles of relieving fat accumulation and reducing facial fat.

Aiming at the condition of facial skin relaxation, the invention adopts lidocaine, sodium bicarbonate, dexamethasone, compound calcium carbonate, vitamin B1, vitamin B6 and vitamin B12 for compound collocation, wherein the lidocaine injection has good surface penetrating power and anesthetic effect, and improves the injection effect; the compound calcium carbonate, the vitamin B1, the vitamin B6 and the vitamin B12 are adopted to lock the moisture of skin cells, supply the nutrition components to subcutaneous cells, promote the activity of the subcutaneous cells and promote the growth of the cells, thereby playing the role of relieving the state of skin wrinkles and unevenness and providing a new medicine combination selection for clinical treatment.

The embodiments described above are some, but not all embodiments of the invention. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.